Patient Advocates In Research (PAIR)Danville, California, United States
Disclosure(s): Apellis Pharmaceuticals, Inc.: Advisor/Consultant; Kinnate Biopharma: Advisor/Consultant
84 - Improving Traditional Registrational Trial Endpoints: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin-Structure Infections
Thursday, October 17, 202411:00 AM – 11:15 AM US PT
